Robert Kennedy fires the evidence-review chairs to defund prevention at scale

The administration’s claim that it seeks greater transparency and more frequent meetings is simply the bureaucratic language for defunding prevention at scale. On May 11, Health Secretary Kennedy sent letters to Dr. John Wong and Dr. Esa Davis — the chair and vice chair of the U.S. Preventive Services Task Force — informing them that their appointments were terminated immediately, before the end of their multiyear terms. The letters, obtained by The New York Times and described by the Associated Press, praised the doctors’ “leadership, contributions and expertise” and encouraged them to reapply, but offered no specific reason for the firings. Kennedy said the move was part of an effort to provide “clarity, continuity and confidence” — the language of bureaucratic housekeeping, deployed against a body whose entire function is to make housekeeping impossible.

It is worth being precise about what the task force actually does, because the public discourse about medical “guidelines” has the misleading habit of treating them as advisory documents rather than the executable code of the insurance apparatus. The task force is a panel of clinicians and researchers who systematically review the evidence on preventive care — screenings, counseling, preventive medications — and issue letter grades. An “A” means the evidence is strong that the service helps, and the Affordable Care Act requires most private insurers to cover it without a co-pay or deductible. A “B” means the evidence is good but not overwhelming, and coverage still applies. When the task force changes a grade — say, lowering the starting age for colorectal cancer screening from 50 to 45 — tens of millions of patients gain access to a service that their insurance must now cover as a matter of federal law. The preventive-services guarantee — the part of the law that made colonoscopies, mammograms, statins, and depression screening free at the point of use for roughly 150 million people — rests on a simple premise: that the decision about what qualifies should be made by people who read the studies, not by people who read the polls.

That premise is what Kennedy is dismantling. The firings are the culmination of a deliberate campaign to keep the task force from producing any new evidence that might constrain the Secretary’s policy discretion. For much of the past year, the Department of Health and Human Services indefinitely postponed the panel’s scheduled public meetings, using its scheduling authority under the Federal Advisory Committee Act to keep the task force in limbo without formally disbanding it — a maneuver that lets HHS freeze guideline development while preserving the appearance of institutional continuity. Former chair Dr. Michael Silverstein, who served a decade on the task force, told the AP he had never experienced that kind of government intrusion. The panel was barred from publishing its finalized update to the cervical cancer screening guideline — a guideline that directly affects how often millions of women receive Pap and HPV tests without cost-sharing — and was not permitted to begin updating recommendations on maternal depression. These are not abstract quarrels about process. They are decisions to withhold, from clinicians and patients, the current best reading of the evidence on which lives depend, while the political leadership decides what it wants the evidence to say.

In a Selkirk rolling-mill workshop, there was a strict distinction between preventive maintenance and catastrophic failure. Checking the gearboxes for vibration and pulling the drive belts before the casting heat hit was boring, repetitive work that did not feel like a heroic intervention. Dismantling preventive care works by the inverse calculus: when the cervical‑cancer screening update is shelved, the bill for late‑stage treatment lands on the same ratepayer who was told the review was a bureaucratic luxury. The inheritance of extraction in this country no longer relies on buying heavy industry and running the margins into the ground; it relies on convincing the ratepayer that the preventative maintenance they are already paying for is actually a form of government overreach.

The technique is old enough to have a name. In 2010, the historians Naomi Oreskes and Erik Conway documented the playbook in Merchants of Doubt: when a body of scientific consensus threatens a policy objective, attack the body as unreliable, starve it of oxygen, and then install a more tractable alternative. The industry version — tobacco, fossil fuels, opioids — involved paid consultants and front groups. The public-health version involves a Senate-confirmed secretary with a stated mandate to “reform” the very structures that make evidence inconvenient. Kennedy told lawmakers last month that the task force was “lackadaisical” and that he wanted it to provide “for the first time, transparency.” What Kennedy means by transparency, almost certainly, is a panel whose conclusions align with his. The offer to the fired doctors to reapply for their jobs is not a reinstatement path; it is a bureaucratic mockery — a performance of due process while the institutional machinery is disabled.

The practical consequence, for now, is a hole where the cervical cancer screening guideline should be, a delay on maternal depression, and an open question about what happens when the next “A” or “B” recommendation conflicts with a political priority. The harder consequence is harder to perceive, because it is a withdrawal of infrastructure rather than a benefit cut. The preventive-services guarantee was never a right patients could enforce directly; it was a scaffolding of interlocking statutory and regulatory components — the task force’s evidence grading, the HHS Secretary’s adoption, the ACA’s coverage mandate — that together produced an outcome. When you remove the evidence-grading pillar, the rest of the machine still runs for a while, because insurers have built the current grades into their systems and patients have come to expect the coverage. But the next update never arrives. The new screening tool that detects cancer earlier stays classified as experimental. The machine starts to coast, and then it drifts, and then, one day, the colonoscopy bill arrives with a co-pay and the patient discovers that the guarantee was never a promise someone could call, only a procedure someone could cancel.

The maintenance schedule has been cancelled. The breakdown will be billed at full price.